Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-11-04Clinical Trial Update: Bone Density in Patients With Schizophrenia
A completed clinical trial investigating bone density in patients with schizophrenia, including individuals with alcohol use disorders, has …
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating adjunctive aripiprazole in clozapine-treated patients with refractory schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-06Clinical Trial Update: Seroquel Long-Term NIS for Schizophrenia Patients
Completion of a long-term non-interventional study of quetiapine (Seroquel) in patients with schizophrenia and schizoaffective disorder has …
-
CLINICAL_TRIALS trial_result · 2008-10-02Clinical Trial Update: A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia [Phase 1]
Phase 1 study update on adjunctive treatment for cognitive deficits in schizophrenia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: Energy Homeostasis Under Treatment With Atypical Antipsychotics [Phase 4]
Phase 4 clinical trial update evaluating energy homeostasis in schizophrenia patients treated with atypical antipsychotics. The study status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness
Three-year follow-up results from a randomized controlled trial of an intervention for tobacco dependence in individuals with a psychotic il…
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain [Phase 2]
Phase 2 study evaluating the efficacy and safety of mifepristone to prevent olanzapine-induced weight gain has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-16Clinical Trial Update: Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy [Phase 4]
Phase 4 clinical trial investigating pharmacological therapy to modulate regional brain activation in schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Amisulpride in Schizophrenic Acute Phase Patients [Phase 4]
Phase 4 clinical trial update showing completion of a study evaluating amisulpride in the acute phase of schizophrenia.
-
CLINICAL_TRIALS trial_result · 2008-08-26Clinical Trial Update: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder [NA]
A completed clinical trial evaluating the effects of risperidone and olanzapine in patients with schizophrenia, schizoaffective disorder, ma…
-
CLINICAL_TRIALS trial_result · 2008-08-22Clinical Trial Update: Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol [Phase 4]
Phase 4 trial comparing the efficacy and tolerability of flunarizine versus haloperidol in schizophrenia, reporting on comparative effective…
-
CLINICAL_TRIALS trial_result · 2008-08-12Clinical Trial Update: Minocycline for the Treatment of Early-Phase Schizophrenia [Phase 3]
A Phase 3 trial evaluating minocycline for negative and cognitive symptoms in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-31Clinical Trial Update: Efficacy of Galantamine to Treat Schizophrenia [Phase 4]
A Phase 4 trial assessing galantamine for schizophrenia has been terminated, with no efficacy results reported in the snippet.
-
CLINICAL_TRIALS trial_result · 2008-07-31Clinical Trial Update: A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients [Phase 2]
A Phase 2, single-center, double-blind trial evaluating MEM 3454 for effects on P50 sensory gating and mismatch negativity in schizophrenia …
-
CLINICAL_TRIALS trial_result · 2008-07-25Clinical Trial Update: A Clinical Trial on the Antipsychotic Properties of Cannabidiol [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the antipsychotic properties of cannabidiol in schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia [Phase 2, Phase 3]
This document reports the completion of a Phase 2/Phase 3 clinical trial evaluating oxcarbazepine as an adjunct to antipsychotic therapy in …
-
CLINICAL_TRIALS trial_result · 2008-07-23Clinical Trial Update: Efficacy of Selegiline in Negative Symptoms of Schizophrenia [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the efficacy of selegiline for negative symptoms in schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone [NA]
Pfizer-sponsored trial evaluating the differential sensitivity of two spatial working memory tests in individuals with schizophrenia treated…
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions [Phase 3]
A Phase 3 clinical trial comparing two state-of-the-art interventions for treating psychotic symptoms in youth with a first episode of schiz…
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey
The FOCUS trial evaluating FazaClo (clozapine) for schizophrenia has completed, with weight gain and sialorrhea noted as conditions of inter…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Treatment of Neuroleptic Induced Acute Akathisia With Trazodone [Phase 4]
A Phase 4 trial evaluating trazodone for treatment of neuroleptic-induced acute akathisia in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients [Phase 3]
A Phase 3 trial comparing weight changes in stable schizophrenia patients treated with bifeprunox versus quetiapine has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Pregnenolone in the Management of Schizophrenia Patients [Phase 1]
A Phase 1 clinical trial evaluating pregnenolone for the management of schizophrenia has completed, reporting early safety and tolerability …
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Switch Study of Existing Atypical Antipsychotics to Bifeprunox [Phase 3]
This update notes the completion of a Phase 3 switch study evaluating transitioning from existing atypical antipsychotics to bifeprunox for …
-
CLINICAL_TRIALS trial_result · 2008-05-16Clinical Trial Update: Digital Voice Analysis in Patients With Schizophrenia
Clinical trial evaluating digital voice analysis in patients with schizophrenia has completed.